Hologic, Inc.

Hologic develops and supplies diagnostic products, medical imaging systems, and surgical products for womens health. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides molecular diagnostic assays, viral load assays, and tests for vaginal infections and SARS-CoV-2 detection. Hologic also offers breast cancer care solutions, including 3D digital mammography systems and image analytics software. The company provides surgical products, such as hysteroscopic tissue removal and endometrial ablation systems. Additionally, it offers dual energy X-ray systems and mini C-arm systems for minimally invasive orthopedic procedures. Hologic sells its products through various channels and is headquartered in Marlborough, Massachusetts.

Overview

Sector

Medical Instruments & Supplies

Target Price

102.1 USD

Current Price

64.0 USD

Potential

60%

Strengths

With an appreciation Potential of 59.93%, based on our fundamental analysis, it suggests the stock may be undervalued.
Current Price to Earnings Ratio (18.74) is lower than the sector mean (85.51).
Price to book ratio (2.88) is lower than the sector mean (3.86).
The company has low debt. Net Debt to EBITDA Ratio is 0.28 and it is lower than the sector mean.
The company has high returns. ROIC (16.77%) is higher than the sector mean (8.23%).
EV/EBIT (15.37) is lower than the sector mean.
Price to free cash flow (12.92) is lower than the sector mean.
Strong EBITDA Margin of 33.36%.

Weaknesses

No significant weaknesses identified based on the analyzed metrics.

Key Financial Data

Indicator	Value
PER	18.8
EV/EBITDA	11.3
Price/Free Cash Flow'	13.0
ROIC	16.8%
Net Debt/EBITDA	0.3